iShares U.S. Pharmaceuticals ETF (IHE)
BlackRock / iShares
- Page updated:
- Sep 8, 2026
- Data as of:
- Sep 2, 2026
Fund identity
- Ticker
- IHE
- Fund name
- iShares U.S. Pharmaceuticals ETF
- Fund type
- ETF
- Listing venue
- NYSE Arca
- Currency
- USD
- Domicile
- US
- Inception
- May 1, 2006
Structure and strategy
- Sponsor
- BlackRock / iShares
- Management approach
- Passive
- Strategy
- Seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index.
- Portfolio scope
- U.S. pharmaceutical equities
- Portfolio implementation
- Index tracking
- Benchmark
- Dow Jones U.S. Select Pharmaceuticals Index
- Benchmark symbol
- DJSPHMT
- Asset class
- Equity
- Category
- U.S. Pharmaceuticals
Costs and minimums
- Net expense ratio
- 0.37%
- Expense ratio
- 0.37%
- Ongoing fee as of
- Sep 7, 2026
Size and distributions
- Assets under management
- $1.68B
- Assets under management scope
- Fund
- Distribution frequency
- Quarterly
Sources
- iShares U.S. Pharmaceuticals ETF issuer fund page — BlackRock / iShares · data as of Sep 7, 2026
Learn the basics
ROIStreet publishes this reference data for education and research. Figures are as of the dates shown, are not real-time quotes, and are not investment advice. Verify details with the issuer or provider before acting.